How Eris is weaving a success story around its 4 distressed acquisitions

Eris Lifesciences started new neuro-psychiatry and women healthcare divisions for Strides portfolio and a new nutrition division for UTH portfolio

After growing organically for almost a decade, Eris Lifesciences made 4 acquisitions of distressed businesses in about a couple of years and is now hoping to turn them around.

Of the four acquisitions, Eris has managed to grow the contributions from Amay and Kindex to its revenues by a whopping 211 per cent this fiscal from FY17. The Ahmedabad-headquartered company is working actively to turn around the other two - Strides (its largest acquisition so far) and niche nutrition player UTH Healthcare.  

The company paid around Rs 6.3 billion for these assets and now analysts expect these to